1. Home
  2. WDFC vs IRON Comparison

WDFC vs IRON Comparison

Compare WDFC & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WD-40 Company

WDFC

WD-40 Company

HOLD

Current Price

$205.05

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$69.70

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDFC
IRON
Founded
1953
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
WDFC
IRON
Price
$205.05
$69.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$270.00
$103.18
AVG Volume (30 Days)
111.3K
423.0K
Earning Date
04-09-2026
05-07-2026
Dividend Yield
1.91%
N/A
EPS Growth
30.92
N/A
EPS
2.78
N/A
Revenue
$488,109,000.00
N/A
Revenue This Year
$8.23
N/A
Revenue Next Year
$5.85
$283.52
P/E Ratio
$73.78
N/A
Revenue Growth
19.49
N/A
52 Week Low
$175.38
$40.00
52 Week High
$253.24
$99.50

Technical Indicators

Market Signals
Indicator
WDFC
IRON
Relative Strength Index (RSI) 44.83 56.93
Support Level $199.17 $64.39
Resistance Level $212.45 $71.53
Average True Range (ATR) 5.51 3.22
MACD 0.33 0.02
Stochastic Oscillator 46.87 65.48

Price Performance

Historical Comparison
WDFC
IRON

About WDFC WD-40 Company

WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: